Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2015-11-09
2016-12-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area
NCT05538728
Safety and Effectiveness of Sculptra 011611 for Improvement in Appearance of Gluteal Skin Irregularities
NCT07324564
Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles
NCT04124692
Evaluation of the Effectiveness and Safety of Diluted RADIESSE® in the Treatment of Décolleté Wrinkles
NCT05163353
Lutronic Genius System for Neck Treatment
NCT03534609
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sculptra
Sculptra, an injectable implant containing microparticles of ply-L-lactic acid, carboxymethylcellulose, non-pyrogenic mannitol and sterile water, will be injected into the decolletage.
Sculpta
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sculpta
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged from 40-70 years on the day of screening
* No known medical conditions that may interfere with study participation
* Moderate to severe crepiness and wrinkling of the décolletage
* Willingness to not use any products on their décolleté for the duration of the study
* Read, understand, and sign informed consent forms
* Willingness to sign photography release form
* Willing and able to comply with all follow-up requirements
* Willingness to undergo a series of three Sculptra injections, 2-3 months apart, in their décolletage
Exclusion Criteria
* Any medical condition which could interfere with the treatment
* Inability or unwillingness to follow the treatment schedule
* Inability or unwillingness to sign the informed consent
* History of poor wound healing
* History of keloid formation
* History of HIV, hepatitis, immuno-compromised
* Pregnant or lactating
* Previous use of deep chemical peels on the treatment area
* Previous injections of Sculptra in the décolletage
* Known hypersensitivity to Sculptra or any of its ingredients
* Previous laser or light based treatments to the treatment area 6 months prior to the screening visit
40 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Skin Laser & Surgery Specialists
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David J. Goldberg, MD
David J. Goldberg, MD, JD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCULPTDEC01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.